Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD)

PHASE4CompletedINTERVENTIONAL
Enrollment

924

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

August 31, 2012

Conditions
Major Depressive Disorder
Interventions
DRUG

desvenlafaxine succinate sustained-release 50 mg/day

50 mg tablets of DVS SR taken orally once daily for 8 weeks; 1 week of placebo taper

DRUG

desvenlafaxine succinate sustained-release 100 mg/day

100 mg tablets of DVS SR taken orally once daily for 8 weeks (which includes 1 week of titration at 50 mg/day); 1 week of taper at 50 mg/day

DRUG

placebo

50 mg and 100 mg placebo matching tablets taken orally once daily for 8 weeks; 1 week of placebo taper

Trial Locations (61)

10021

Eastside Comprehensive Medical Center, LLC, New York

10023

Medical and Behavioral Health Research Pc, New York

11235

Social Psychiatry Research Institute, Brooklyn

11516

Neurobehavioral Research, Inc, Cedarhurst

18104

Lehigh Center for Clinical Research, Allentown

19063

Suburban Research Associates, Media

19139

CRI Worldwide, LLC, Philadelphia

21208

Pharmasite Research Inc, Baltimore

29201

Carolina Clinical Research Services, Columbia

30080

Carman Research, Smyrna

30308

Atlanta Center for Medical Research, Atlanta

30328

Comprehensive NeuroScience, Incorporated, Atlanta

32216

Clinical Neuroscience Solutions Incorporated, Jacksonville

32751

Florida Clinical Research Center, LLC, Maitland

33407

Janus Center for Psychiatric Research, West Palm Beach

33716

Comprehensive NeuroScience, Inc., St. Petersburg

34741

Accurate Clinical Trials, Inc., Kissimmee

44122

NorthCoast Clinical Trials Inc., Beachwood

44718

Neuro-Behavioral Clinical Research, Inc., Canton

45215

Patient Priority Clinical Sites, LLC, Cincinnati

45417

Midwest Clinical Research Center, Dayton

58103

Prairie St. Johns Clinic - Fargo, Fargo

58104

Odyssey Research, Fargo

Plains Medical Clinic, Fargo

60048

Capstone Clinical Research, Libertyville

60435

Joliet Center for Clinical Research, Joliet

60523

American Medical Research, Inc., Oak Brook

60563

AMR-Baber Research Inc., Naperville

63301

Midwest Research Group, Saint Charles

66211

Psychiatric Associates, Overland Park

67214

Via Christi Research, Wichita

69101

Heartland Pharma Development, North Platte

72223

Arkansas Psychiatric Clinic Clinical Research Trials, P.A., Little Rock

73116

Cutting Edge Research Group, Oklahoma City

75230

KRK Medical Research, Dallas

75231

FutureSearch Trials of Dallas, Dallas

77090

Red Oak Psychiatry Associates, PA, Houston

78731

FutureSearch Trials, Austin

84123

Radiant Research, Inc., Murray

85020

Dedicated Clinical Research, Phoenix

Deidcated Clinical Research, Phoenix

90210

Southwestern Research, Incorporated, Beverly Hills

90502

Collaborative Neuroscience Network, Inc. South Bay, Torrance

91007

Pacific Clinical Research Medical Group, Arcadia

91106

Pasadena Research Institute, LLC, Pasadena

91403

California Neuroscience Research Medical Group, Inc, Sherman Oaks

91786

Pacific Clinical Research Medical Group, Upland

91950

Synergy Clinical Research Center, National City

92027

Synergy Clinical Research of Escondido, Escondido

92108

Affiliated Research Institute, San Diego

92121

Clinical Innovations, Inc., San Diego

92506

Clinical Innovations, Inc., Riverside

92591

Viking Clinical Research Center, Temecula

92626

Clinical Innovations, Inc., Costa Mesa

94612

Pacific Research Partners, Oakland

97210

Oregon Center for Clinical Investigations, Inc., Portland

Summit Research Network (Oregon), Inc., Portland

98033

Eastside Therapeutic Resource, Kirkland

98104

Summit Research Network (Seattle) LLC, Seattle

08053

CRI Worldwide, LLC, Marlton

02865

Lincoln Research, Lincoln

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY